Target intelligence / Profile preview

Hemagglutinin of Influenza A Virus H5N1 Subtype (None)

Target
None
Molecular classification
Glycoprotein, Viral protein, Type I transmembrane protein
01

Overview

Hemagglutinin (HA) is a surface glycoprotein and the principal antigenic determinant of the influenza A virus, including the H5N1 subtype. It plays a critical role in viral entry by mediating both attachment to host cell receptors and subsequent membrane fusion. The HA protein is also central to determining host specificity, pathogenicity, and immune response. HA binds to sialic acid-containing receptors on host cells and after endocytosis into host cells, low pH triggers conformational changes in HA that drive fusion between viral and endosomal membranes. Major antigenic sites are located on the globular head; these regions are targets for neutralizing antibodies but also undergo frequent mutation (antigenic drift). Highly Pathogenic Avian Influenza (HPAI) strains like A(H5N1) possess polybasic cleavage sites within their HA proteins. This allows ubiquitous cellular proteases to activate them efficiently contributing to systemic infection potential in birds and increased virulence in mammals. Mutations affecting its structure—especially at receptor binding or cleavage sites—can dramatically alter transmissibility between species.

02

Mechanism of action

Attachment to host cell receptors; mediation of membrane fusion

03

Biological functions

Receptor bindingMembrane fusionViral entryAntigen presentation
04

Disease associations

InfectionInfluenzaAvian influenzaZoonotic disease
05

Safety considerations

Antigenic driftPotential for zoonotic transmissionHigh pathogenicityRisk of pandemic
06

Biomarkers

Antibody titers against hemagglutinin

Beyond the preview

Go deeper on Hemagglutinin of Influenza A Virus H5N1 Subtype (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin of Influenza A Virus H5N1 Subtype (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call